INS and Gitelman syndrome: In addition, hypomagnesemia found in Gitelman ́s syndrome patients is implicated in a reduced tyrosine kinase activity at the insulin receptor level, and dysregulates K+ -ATP and L-type Ca2+ channels in the ß cells, which impairs insulin activity and secretion.